Form 8-K IsoRay, Inc. For: Feb 18

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. EXPE
3. ARM
4. BROS
5. FIS
6. DDOG
7. QCOM
8. EW
9. ZG
10. W

Go back to Form 8-K IsoRay, Inc. For: Feb 18

IsoRay (ISR) Reports In-Line Q2 Loss of 2c/Share; Offers Commentary

February 18, 2015 8:17 AM EST

IsoRay (AMEX: ISR) reported Q2 EPS of ($0.02), in-line with the analyst estimate of ($0.02). Revenue for the quarter came in at $1.07 million versus the consensus estimate of $1.07 million.

IsoRay's team remains focused in diversifying its product offerings through institutional based studies designed to address various aggressive cancers that to date often fail current standard of care options. Management is hopeful that the lingering decline in the prostate market may be bottoming out. Management anticipates seeing modest gains in IsoRay's market share as well as some revenue growth in the coming quarters. We... More